Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The association of β-arrestin2 polymorphisms with response to antidepressant treatment in depressed patients.

Progress in neuro-psychopharmacology & biological psychiatry - 2 Feb 2018

Petit Anne-Cécile, El Asmar Khalil, David Denis J, Gardier Alain M, Becquemont Laurent, Fève Bruno, Verstuyft Céline, Corruble Emmanuelle

Abstract excerpt

The study of genetic polymorphisms involved in antidepressants (AD) response is essential to provide a personalized medicine approach in the field of depression. β-arrestin 2 (ARRB2) is a candidate gene in the pharmacogenetics of AD as it is involved in the signaling cascade downstream of numerous neurotransmitter receptors. We investigated the association between five ARRB2 single nucleotide polymorphisms...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to beta-Arrestin 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Depressive Disorder, Major

Share to Genetic Association Studies

Share to Multivariate Analysis

Share to Pharmacogenomic Variants

Share to Polymorphism, Single Nucleotide

Share to Treatment Outcome

Source

Identifiers

PMID: 29031912
DOI: 10.1016/j.pnpbp.2017.10.006

Genes

ARRB2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The association of β-arrestin2 polymorphisms with response to antidepressant treatment in depressed patients.PMID 29031912Read ↗

Association of ARRB1 polymorphisms with the risk of major depressive disorder and with treatment response to mirtazapine.Semantic proximity Read ↗

Discovery of a novel pharmacogenomic biomarker on ANK3gene for liafensine, a triple reuptake inhibitor for treatment-resistant depressionSemantic proximity Read ↗

β-Arrestin2 influences the response to methadone in opioid-dependent patients.Semantic proximity Read ↗

Orphan G Protein Coupled Receptors in Affective Disorders.Semantic proximity Read ↗

A genome-wide association study of antidepressant response in Koreans.Semantic proximity Read ↗

A randomized, double-blind, placebo-controlled phase 2b trial using the novel predictive genetic biomarker DGM4 for liafensine in treatment-resistant depressionSemantic proximity Read ↗

CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) study.Semantic proximity Read ↗

DRD2 genotypic and haplotype variation is associated with improvements in negative symptoms after 6 weeks' amisulpride treatment.Semantic proximity Read ↗

FAS -670A>G genetic polymorphism Is associated with Treatment Resistant Depression.Semantic proximity Read ↗

Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder.Semantic proximity Read ↗

Neuronal cell adhesion genes and antidepressant response in three independent samples.Semantic proximity Read ↗

The relationship between single nucleotide polymorphisms in 5-HT2A signal transduction-related genes and the response efficacy to selective serotonin reuptake inhibitor treatments in Chinese patients with major depressive disorder.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.